TODD STRATEGY GROUP

Lobbying for GENENTECH, INC. · Biotechnology corporation.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Oct 12, 2025

Lobbying activity 2

Medicare/Medicaid

Medicare and Medicaid payment issues. 340B. Implementation of Inflation Reduction Act of 2022.

Pharmacy

Prescription drug payment reform. Supply chain. Strategic National Stockpile.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.